1731.TW
Strong BuyFull HouseFLAGMaywufa Company Ltd. · Healthcare · Taiwan · $88M · Avg Vol: $59K/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Maywufa sells health foods and consumer products in Taiwan, with a reasonable quality score (Q69) but weak momentum (M48) and a marginal consensus trim, and there is no supportive filings evidence. Nothing adverse is known, so the default applies.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT MAYWUFA COMPANY LTD.
Read
Maywufa Company Ltd. manufactures hair care products and distributes pharmaceuticals and medical devices. The company's competitive moat is driven by its leading domestic brand in hair coloring and personal care, complemented by a stable pharmaceutical distribution business. It operates as a diversified healthcare and consumer defensive player with strong brand loyalty and regulatory expertise.
FINANCIAL SUMMARY (TWD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 1.2B | 1.3B | 1.5B | 1.6B | 8.4% | 1.6B |
| EPS (TWD) | 1.24 | 1.22 | 1.27 | 1.30 | 1.36 | 2.4% | 1.51 |
| Shares | — | 132.9M | 132.9M | 132.9M | 132.9M | 0.0% | 132.9M |
| Debt | — | 227.0M | 442.7M | 673.8M | 641.8M | 41.4% | 639.8M |
| Equity | — | 2.0B | 2.0B | 2.1B | 2.2B | 2.7% | — |
| Op CF | — | 147.9M | 244.3M | 215.7M | 223.2M | 14.7% | 250.7M |
| Inv CF | — | 36.2M | -308.4M | -295.9M | 22.1M | — | — |
| Fin CF | — | -245.5M | 66.5M | 74.3M | -196.5M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1731.TW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1731.TW | Maywufa Company Ltd.(you) | $88M | 94 | Strong Buy |
| 8432.TWO | TSH Biopharm Corporation Limited | $62M | 100 | Strong Buy |
| 1720.TW | Standard Chemical & Pharmaceutical Co., Ltd. | $351M | 97 | Strong Buy |
| 1760.TW | Panion & Bf Biotech Inc. | $158M | 76 | Buy |
| 1707.TW | Grape King Bio Ltd | $418M | 95 | Strong Buy |
| 3705.TW | YungShin Global Holding Corporation | $471M | 98 | Strong Buy |
| 4746.TW | Formosa Laboratories, Inc. | $188M | 72 | Buy |
| 4105.TWO | TTY Biopharm Company Limited | $612M | 97 | Strong Buy |
| 3054.TW | LIWANLI Innovation Co., Ltd. | $145M | 53 | Hold |
| 4127.TWO | Tien Liang BioTech Co., Ltd. | $114M | 38 | Hold |
Peer medians: ROE 4.1% · P/E 15.7x · Gross margin 41.6%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.